The Clorox Company
CLX
$117.61
-$0.16-0.14%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.76B | 6.77B | 7.10B | 7.02B | 7.17B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.76B | 6.77B | 7.10B | 7.02B | 7.17B |
| Cost of Revenue | 3.77B | 3.77B | 3.90B | 3.86B | 3.98B |
| Gross Profit | 2.98B | 3.00B | 3.21B | 3.16B | 3.19B |
| SG&A Expenses | 1.84B | 1.86B | 1.90B | 1.98B | 2.01B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 14.00M | 12.00M | 6.00M | 12.00M | 19.00M |
| Total Operating Expenses | 5.75B | 5.76B | 5.92B | 5.97B | 6.13B |
| Operating Income | 1.01B | 1.01B | 1.19B | 1.05B | 1.04B |
| Income Before Tax | 986.00M | 1.01B | 1.08B | 943.00M | 647.00M |
| Income Tax Expenses | 216.00M | 205.00M | 254.00M | 234.00M | 179.00M |
| Earnings from Continuing Operations | 770.00 | 803.00 | 824.00 | 709.00 | 468.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.00M | -12.00M | -14.00M | -15.00M | -11.00M |
| Net Income | 755.00M | 791.00M | 810.00M | 694.00M | 457.00M |
| EBIT | 1.01B | 1.01B | 1.19B | 1.05B | 1.04B |
| EBITDA | 1.23B | 1.23B | 1.40B | 1.26B | 1.25B |
| EPS Basic | 6.15 | 6.41 | 6.56 | 5.60 | 3.69 |
| Normalized Basic EPS | 4.61 | 4.62 | 5.49 | 4.79 | 4.75 |
| EPS Diluted | 6.12 | 6.38 | 6.53 | 5.57 | 3.66 |
| Normalized Diluted EPS | 4.59 | 4.59 | 5.46 | 4.76 | 4.73 |
| Average Basic Shares Outstanding | 490.77M | 492.94M | 494.10M | 495.23M | 496.11M |
| Average Diluted Shares Outstanding | 492.74M | 495.49M | 497.15M | 498.46M | 498.64M |
| Dividend Per Share | 3.70 | 4.92 | 4.90 | 4.88 | 4.86 |
| Payout Ratio | 79.74% | 76.11% | 74.32% | 86.60% | 131.07% |